Loading...
Price History
Market Data
| Market Cap | 6.25M |
| P/E Ratio | - |
| P/B Ratio | 1.41 |
| EPS | -2.49 |
| Dividend Yield | - |
| D/E Ratio | 0.36 |
| Current Ratio | 3.25 |
| Currency | USD |
Key Financial Metrics
4.46M
Revenue
-4.03M
Net Income
-2.49
EPS (Diluted)
-5.37M
Free Cash Flow
Profitability
Gross Margin
5.6%
Operating Margin
-118.1%
Net Profit Margin
-90.3%
EBITDA
-5.12M
Returns & Efficiency
Return on Assets (ROA)
-66.7%
Return on Equity (ROE)
-90.8%
Dividend Yield
-
EPS
-2.49
Financial Health
Total Assets
6.03M
Total Debt
-
Debt to Equity
0.36x
Current Ratio
3.25
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | IRVINE, CA |
| Fiscal Year | 2025 |
Peers
44.33B
P/E: --
9.12B
P/E: --
VENAXIS, INC.
RIOT
9.12B
P/E: --
BIOPTIX, INC.
RIOT
9.12B
P/E: --
9.12B
P/E: --
6.07B
P/E: 28.0
ARCA BIOPHARMA, INC.
ORKA
3.74B
P/E: --
3.74B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$6.25M
P/E Ratio (TTM)-
Price to Book1.41
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin5.6%
Operating Margin-118.1%
Net Margin-90.3%
ROE-90.8%
ROA-66.7%
Leverage & Liquidity
Debt to Equity0.36
Current Ratio3.25
Total Debt-
Total Assets$6.03M
Stockholders' Equity$4.43M
Income Statement (FY 2025)
Revenue$4.46M
Gross Profit$250.00K
Operating Income$-5.26M
Net Income$-4.03M
EPS (Diluted)$-2.49
Cash Flow (FY 2025)
Free Cash Flow$-5.37M
Cash & Equivalents$2.54M
Revenue Growth-16.1%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 17571 VON KARMAN AVENUE IRVINE, CA 92614 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 952645573 |
| Fiscal Year End | 0531 |
| Shares Outstanding | 2.91M |
| Stockholders' Equity | $4.43M |
| Cash & Equivalents | $2.54M |
Recent Filings
View All
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-01-14
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-10-20
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-10-14
Local
10-K/A
Amended Annual Report
Amendment to previously filed annual report
Filed: 2025-09-26
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-08-29
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-04-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-01-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-10-15
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-09-30
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-08-28
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-04-12
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-01-16
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-10-12
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2023-09-27
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | BIOMERICA INC |
| Ticker | BMRA |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | IRVINE, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 6.25M |
| Revenue | 4.46M |
| Net Income | -4.03M |
| P/E Ratio | - |
| EPS | -2.49 |
| Net Margin | -90.3% |
| ROE | -90.8% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...